MIST
Milestone Pharmaceuticals Inc.NASDAQHealthcare$1.38+5.34%ClosedMarket Cap: $118.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.05
P/S
84.44
EV/EBITDA
-1.93
DCF Value
$0.15
FCF Yield
-37.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
96.2%
Operating Margin
-4030.2%
Net Margin
-4078.8%
ROE
-656.8%
ROA
-55.5%
ROIC
-62.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.5M | 97.8% | $-17.4M | $-17.4M | $-0.16 | — |
| FY 2025 | $1.5M | 92.6% | $-62.5M | $-63.1M | $-0.75 | — |
| Q3 2025 | $0.00 | -Infinity% | $-11.9M | $-11.9M | $-0.12 | — |
| Q2 2025 | $0.00 | NaN% | $-12.5M | $-13.0M | $-0.20 | — |
| Q1 2025 | $0.00 | NaN% | $-20.5M | $-20.8M | $-0.31 | — |
| Q4 2024 | $0.00 | -Infinity% | $-12.4M | $-12.4M | $-0.20 | — |
| FY 2024 | $0.00 | NaN% | $-42.1M | $-41.5M | $-0.67 | — |
| Q3 2024 | $0.00 | NaN% | $-9.6M | $-9.4M | $-0.14 | — |
| Q2 2024 | $0.00 | NaN% | $-9.7M | $-9.4M | $-0.14 | — |
| Q1 2024 | $0.00 | NaN% | $-10.5M | $-10.4M | $-0.21 | — |
| Q4 2023 | $0.00 | -Infinity% | $-13.9M | $-13.6M | $-0.41 | — |
| FY 2023 | $1.0M | 100.0% | $-61.1M | $-59.7M | $-1.39 | — |